GleanMark

BEONEDIRECT Trademark

BEONEDIRECT is a USPTO trademark filed by BEONE MEDICINES I GMBH. Status: Pending.

Trademark Facts

MarkBEONEDIRECT
Serial Number99484495
StatusPending
Filing Date2025-11-07
Mark TypeWord
Nice Classes005 (Pharmaceuticals), 009 (Electronics & Software), 035 (Advertising & Business), 036 (Financial Services), 038 (Telecommunications), 041 (Education & Entertainment), 042 (Software & IT), 044 (Medical Services)
OwnerBEONE MEDICINES I GMBH
Attorney of RecordKristen Ruisi
Prosecution Events17
Latest EventCNSA on 2026-04-23

Goods & Services

Class 005: Pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemico-pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; drugs in the nature of pharmaceutical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for pharmaceutical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; medicines for human purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Injectable pharmaceuticals for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; crude drugs in the nature of pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Biochemical preparations for medical use for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Class 009: Downloadable mobile application for providing medical information related to healthcare namely, cancer, autoimmune and inflammatory disease, rheumatoid arthritis, cardiovascular diseases and infectious diseases; downloadable computer software for providing medical information related to healthcare namely, cancer, autoimmune and inflammatory disease, rheumatoid arthritis, cardiovascular diseases and infectious diseases; downloadable software for enabling patients to request, receive, and manage prescriptions and orders of the pharmaceuticals and over the counter medicated preparations; Class 035: Retail pharmacy services; mail order pharmacy services; online retail pharmacy services; pharmaceutical services, namely, processing online and telephone prescription orders in retail and central fill pharmacies; providing business contact information in the field of community oncology experts; Class 036: Providing financial assistance to patients and healthcare providers for prescription drug costs in the fields of cancer, autoimmune and inflammatory disease, rheumatoid arthritis, cardiovascular diseases and infectious diseases; providing information about patient reimbursement and insurance coverage for pharmaceuticals; pharmacy benefit management services; Class 038: Providing a web site for synchronous and asynchronous communication and for connection of physicians with their patients regardless of medical organization or geographic location; electronic exchange of medical records across a nationwide health information network; transmission of information and images relating to pharmaceuticals and medicine; Class 041: Educational services, namely, providing a website featuring blogs and non-downloadable publications in the nature of informational articles and guides in the fields of cancer, autoimmune and inflammatory disease, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Educational services, namely, providing on-line newsletters in the fields of cancer, autoimmune and inflammatory disease, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Providing online non-downloadable videos in the fields of cancer, autoimmune and inflammatory disease, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Class 042: Research and development of new products for others; technological research in the field of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical research; scientific research in the nature of conducting clinical trials for others for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological research; quality control of goods and services for others for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; electronic data storage; material testing; cloud computing featuring software for use in database management, word processing, spreadsheet management, tracking; packaging design; Class 044: Providing medical information; providing a web site featuring medical information; providing medical information, consultancy and advisory services; healthcare services, namely, providing oncology resources in the nature of online databases in the field of cancer information; medical services; telemedicine services; pharmaceutical advice

Recent Prosecution Activity

DateDocumentType
2026-04-20Final ActionFREF
2026-04-17Response to Office ActionROA
2026-03-22Notice of Non-Final Office ActionNFO
2026-03-22XSearch Search SummaryXSS
2026-03-22Non-Final ActionNFIN
2025-11-07ApplicationAPP

USPTO Refusals on Record

Related